Portfolio (Quarterly)
Guide ↗
Atlas Venture Life Science Advisors, LLC
· CIK 0001917529| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KYMR | Kymera Therapeutics, Inc. | Healthcare | 4,578,008.0 | $381.3M | 48.26% | -82K | -1.8% | $83.29 | -4.3% |
| 2 | DYN | Dyne Therapeutics, Inc. | Healthcare | 9,130,465.0 | $165.5M | 20.95% | — | — | $18.13 | -8.8% |
| 3 | SION | Sionna Therapeutics, Inc. | Healthcare | 2,995,602.0 | $120.1M | 15.20% | — | — | $40.09 | -2.1% |
| 4 | — | Disc Medicine, Inc. | — | 1,513,875.0 | $96.8M | 12.25% | — | — | $63.94 | — |
| 5 | QTTB | Q32 Bio, Inc. | Healthcare | 2,092,106.0 | $13.4M | 1.70% | — | — | $6.42 | -5.5% |
| 6 | KRRO | Korro Bio, Inc. | Healthcare | 1,137,149.0 | $12.9M | 1.63% | — | — | $11.32 | -19.2% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%